PRESS RELEASES & STATEMENTS
ICN Statement about falsified medicines at WHO 144th Executive Board
The ICN is particularly emphasized the need to see the issue of falsified medicines as ‘a symptom of a larger problem’, namely a lack of access to high-quality, affordable and effective healthcare. The Council is encouraging the Member State Mechanism to engage with our campaign and to foster collaborative action with Read more…









